The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity is intended for pharmacists who wish to expand their knowledge and skills applicable to the care of patients at risk for opioid overdose.
At the completion of this activity, participants will be able to:
- Describe the history, historical trends, and regulatory changes associated with opium, opiates, and opioids.
- Review the epidemiology of opioid use, misuse, overdose, and the public health impact of the opioid crisis.
- Explain the pharmacology of opioids including, but not limited to, receptor activity and adverse effects.
- Explain the pharmacology of opioid antagonists including, but not limited to, their role in therapy, adverse effects, and special considerations for use.
- Explain the pathogenesis of opioid use disorder, acute opioid withdrawal, and overdose.
- Identify risk factors, clinical presentations, and differential assessments associated with opioid use disorder and opioid overdose.
- Compare the myths and realities of increasing access to opioid antagonists.
- Explain practical considerations for prescribing and dispensing opioid antagonists.
- Describe correct techniques for opioid antagonist administration by caregivers and other responders.
- Counsel patients and caregivers about reversal of opioid overdose.
- Summarize opioid harm reduction principles.
- Apply knowledge of opioid antagonist access laws, stigma reduction, patient education strategies, and community partnerships to prevent opioid-related harm.
Christopher Herndon, PharmD, BCACP, FASHP
Professor
Southern Illinois University Edwardsville
Clinical Associate Professor
St. Louis University School of Medicine
Edwardsville, Illinois
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
- No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.
Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
